| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8714414 | The Journal of Allergy and Clinical Immunology: In Practice | 2018 | 4 Pages |
Abstract
RCU occurs in approximately 13% of patients with CU in our clinic population. Alternative agent use and antihistamine refractoriness appear to place patients at increased risk for recurrence compared with first-line agent use alone.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Julie K. MD, Daniel MD, L. Steven MS, David A. MD,